Cargando…

Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways

A heterogeneous genetic subtype of B-cell precursor acute lymphoblastic leukemia is driven by constitutive kinase-activation, including patients with JAK2 fusions. In our study, we model the impact of a novel JAK2 fusion protein on hematopoietic development in human induced pluripotent stem cells (h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortschegger, Klaus, Husa, Anna-Maria, Schinnerl, Dagmar, Nebral, Karin, Strehl, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304339/ https://www.ncbi.nlm.nih.gov/pubmed/34299194 http://dx.doi.org/10.3390/ijms22147576

Ejemplares similares

The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspective
por: Staerk, Judith, et al.
Publicado: (2012)

Runx1 promotes the development of glioma cells by regulating JAK-STAT signalling pathway
por: Zhang, Yong, et al.
Publicado: (2019)

JAK-STAT signaling in stem cells and their niches in Drosophila
por: Bausek, Nina
Publicado: (2013)

JAK-STAT signaling in cardiomyogenesis of cardiac stem cells
por: Mohri, Tomomi, et al.
Publicado: (2012)

RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
por: Fan, Amy C., et al.
Publicado: (2023)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
por: Gotthardt, Dagmar, et al.
Publicado: (2019)

JAK-STAT3 and somatic cell reprogramming
por: Tang, Yong, et al.
Publicado: (2013)

Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells
por: Hatakeyama, Shigetsugu
Publicado: (2012)

Functions of the Drosophila JAK-STAT pathway: Lessons from stem cells
por: Amoyel, Marc, et al.
Publicado: (2012)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

The Interaction of the IFNγ/JAK/STAT1 and JAK/STAT3 Signalling Pathways in EGFR-Mutated Lung Adenocarcinoma Cells
por: Han, Yaguang, et al.
Publicado: (2022)

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
por: Furqan, Muhammad, et al.
Publicado: (2013)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

JAK-STAT in heterochromatin and genome stability
por: Silver-Morse, Louise, et al.
Publicado: (2013)

JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013)

JAK-STAT: Getting to the heart of the matter
por: Barry, Sean P.
Publicado: (2012)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

The PAX5‐JAK2 translocation acts as dual‐hit mutation that promotes aggressive B‐cell leukemia via nuclear STAT5 activation
por: Jurado, Sabine, et al.
Publicado: (2022)

Heterodimeric JAK-STAT Activation as a Mechanism of Persistence to JAK2 Inhibitor Therapy
por: Koppikar, Priya, et al.
Publicado: (2012)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

JAK–STAT signalling controls cancer stem cell properties including chemotherapy resistance in myxoid liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2019)

The Drosophila JAK-STAT pathway in blood cell formation and immunity
por: Morin-Poulard, Ismaël, et al.
Publicado: (2013)

The involvement of JAK-STAT3 in cell motility, invasion, and metastasis
por: Teng, Yong, et al.
Publicado: (2014)

PAX5-AUTS2: A recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia
por: Denk, Dagmar, et al.
Publicado: (2012)

n-Butylidenephthalide (BP) Maintains Stem Cell Pluripotency by Activating Jak2/Stat3 Pathway and Increases the Efficiency of iPS Cells Generation
por: Liu, Shih-Ping, et al.
Publicado: (2012)

Curcumin induces apoptosis in JAK2‐mutated cells by the inhibition of JAK2/STAT and mTORC1 pathways
por: Petiti, Jessica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdeoo5h78ko9jfl9ur4vc3dfkp